References
- Lennernas H, Abrahamsson B, Persson M, Knutson L. Oral absorption and the Biopharmaceutics Classification System. J Drug Del Sci Tech 2007;17:237–244.
- Amidon G, Lennernas H, Shah VP, Crison R. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 1995;12:413–419.
- Dokoumetzidis A, Macheras P. A century of dissolution research: from Noyes and Whitney to the Biopharmaceutics Classification System. Int J Pharm 2006;321:1–11.
- Ozaki S, Minamisono T, Yamashita T, et al. Supersaturation-nucleation behavior of poorly soluble drugs and its impact on the oral absorption of drugs in thermodynamically high-energy forms. J Pharm Sci 2012;101:214–222.
- Tiwary AK. Modification of crystal habit and the role in dosage form performance. Drug Dev Ind Pharm 2001;27:699–709.
- Raghavan S, Trividic A, Davis AF, Hadgraft J. Crystallization of hydrocortisone acetate: influence of polymers. Int J Pharm 2001;212:213–221.
- Kamiya N, Kagi H, Tsunomori F, et al. Effect of trace lanthanum ion on dissolution and crystal growth of calcium carbonate. J Cryst Growth 2004;267:635–645.
- Kumar S, Chawla G, Bansal A. Role of additives like polymers and surfactants in the crystallization of mebendazole. Yakugaku Zasshi (the Pharmaceutical Society of Japan) 2007;128:281–289.